On August 11, IBM and Hangzhou Cognitive Network Technology Co., Ltd. (hereinafter referred to as “Hangzhou Cognition”) announced that 21 local hospitals plan to use the Memorial Sloan Kettering Cancer Center. IBM Watson for Oncology, based on this cognitive computing platform, helps Chinese doctors obtain personalized evidence-based cancer treatments, which is Watson Health's first partner program in China.

Statistics show that in 2015, there were 4.3 million new cancer cases in China, and more than 2.8 million people died of cancer. At the same time, there are about 12,000 new cancer diagnosis cases every day. In the future, there are a large number of emerging tumors. In order to maintain the use of the best treatment practices, doctors will face increasing pressure from the Japanese.

It is understood that in this cooperation, IBM Watson tumor solution can: quickly sort out the medical records of patients by rating the medical literature to improve the work efficiency of oncologists; determine the personalized diagnosis and treatment plan by analyzing the massive medical literature To assist oncologists to provide patients with high-quality, evidence-based cancer treatment programs; to commemorate the Sloan-Kettering Cancer Center, to obtain the world's top oncology professional level of oncology treatment expertise.

The arrival of IBM Watson will open a new door of hope for cancer patients in China.

In the beginning, IBM Watson for Oncology focused only on breast and lung cancer, and has now expanded to more than a dozen other common physical and blood cancers, such as colon, prostate, bladder, ovarian, cervical cancer, Pancreatic cancer, kidney cancer, liver cancer and uterine cancer, as well as melanoma and lymphoma. After several billions of dollars in acquisitions in recent years, IBM Watson has become stronger and stronger. At this stage, IBM Watson can read 3469 medical monographs, 248,000 papers, 69 treatment plans, 61540 experimental data, 106,000 clinical reports within 17 seconds, and finally propose the optimal according to the patient index information input by the doctor. Personalized treatment plan. To date, IBM Watson's oncology solutions have captured vast amounts of information, including more than 300 medical journals, more than 200 textbooks, and nearly 10 million pages of text. At the same time, the IBM Watson Tumor Solution also incorporates clinical guidelines issued by the National Comprehensive Cancer Network (NCCN).

Hangzhou Cognitive, as the specific implementer of the IBM Watson oncology program in China, will provide sales, service and customer support services, including better localization to bring IBM Watson insights to Chinese doctors. For example, the initial version of Watson's oncology solution in China only supports English, and Hangzhou Cognition will provide some Chinese translation support to ensure that Watson's medical insights can be effectively delivered, including drug labeling and treatment guidelines. Hangzhou Cognition will also be based on Chinese medicine. Guidelines for the use of Chinese medicine.

In addition, Hangzhou Cognition will be based on cooperation with a number of teleconsultation system service providers, combined with its knowledge and resources on regional, medical and national health needs to better promote the promotion of Watson tumor solutions in China. With popularity.

Hangzhou Cognitive CEO Tsang said: "IBM Watson has the ability to improve the way doctors in China and around the world treat cancer. It can provide doctors with insights into treatment options and help doctors target specific individuals according to the specific needs of each patient. In addition to this, Tu Zhen also said that there are some areas of cancer treatment research in the country that are internationally leading. At that time, Hangzhou Cognition will also incorporate these research results into the program library for More doctors learn from.

AKD Special Starch

Application: used in AKD Emulsifier

Product Type: Cassava starch imported from China

Chemical composition: Tapioca starch

Appearance:White powder

Moisture ( % ): ≤ 14.0

Spots ( a / cm2): ≤ 2
Viscosity: 20 ~ 50 s (20%, 40 °C, 4 # Tu's cup)

pH value: 6.0 ~ 7.5

Toxicity: No harm to human health during operation and use

Storage: Store in a cool , dry, ventilated warehouse

Nature: white, gelatinization in low temperature , good fluidity , viscosity stability, aging resistance , the film is good , strong bond , fast drying . Products with low protein content , gelatinization liquid not perishable , no foam , no smell. Good adhesion properties of various fibers , high compatibility with other additives . For AKD emulsifier, the rational use of the product can effectively ensure emulsifying effect and reduce production cost.

Dosage: Production of one ton of 25% emulsifier simply add 192kg of the product
Packing: 25 kg / bag.

Akd Special Starch,Oxidized Starch,Starch For Akd Emulsifer,Cassava Starch

Shandong Tiancheng Chemical Co., Ltd. , https://www.tianchengchemical.com